Company news
FluoGuide A/S news in 2025
FluoGuide A/S's news releases, calls and decks from 2025, newest first.
FluoGuide updates IND submission timing for FG001 – trial initiation unaffected
December 19, 2025
FluoGuide A/S Publishes Interim Report Q3 2025
November 27, 2025
FluoGuide Signs Collaboration Agreement with ZEISS
November 25, 2025
Invitation to FluoGuide A/S (Nasdaq: FLUO) Webcast on 27 November 2025
November 24, 2025
FluoGuide Strengthens Leadership to Advance Clinical Program and Regulatory Approval Strategy
November 5, 2025
FluoGuide Convenes an Extraordinary General Meeting
November 5, 2025
FluoGuide A/S Issue Warrants to Board Members, Executive Management and Employees
November 3, 2025
FluoGuide A/S Completes Directed Share Issue of SEK 104 Million
November 3, 2025
FluoGuide A/S Intends to Carry Out a Directed Share Issue of Approximately SEK 100 Million
November 3, 2025
FluoGuide in Advanced Negotiations on Collaboration Agreement with a World Leading Medical Technology Company
October 28, 2025
FluoGuide Receives Positive FDA Feedback on FG001 in High-Grade Glioma
September 16, 2025
FluoGuide A/S Publishes Interim Report H1 2025
August 28, 2025
Invitation to FluoGuide A/S (Nasdaq: FLUO) Webcast on 28 August 2025
August 22, 2025
FluoGuide Enters Collaboration with Global MedTech Company Olympus
July 21, 2025
FG001 clinical data in High-Grade Glioma is now published in Neurosurgery
June 10, 2025